Non-public fairness agency TPG-backed contract analysis, growth, and manufacturing organisation Sai Life Sciences has filed Draft Purple Herring Prospectus (DHRP) with capital markets regulator SEBI for an preliminary public providing consisting of a recent concern of fairness shares aggregating as much as ₹800 crore in addition to provide on the market (OFS) of greater than 6.15 crore fairness shares.
The OFS will encompass sale of fairness shares by a promoter, two investor shareholders, together with TPG, in addition to just a few promoting shareholders, in response to the DRHP.
The corporate, which gives end-to-end providers throughout the drug discovery, growth and manufacturing worth chain, for small molecule new chemical entities (NCE), to international pharmaceutical innovator firms and biotechnology corporations, proposes to utilise the web proceeds from the recent concern in direction of compensation/prepayment, in full or half, of borrowings totalling ₹600 crore and for basic company functions.
